T Ljung
Overview
Explore the profile of T Ljung including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
395
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ljung T, Sandin S, Langstrom N, Runeson B, Lichtenstein P, Larsson H
Psychol Med
. 2013 Nov;
44(9):1879-87.
PMID: 24176129
Background: It is unclear if psychiatric morbidity among parents bereaved of a child is related to major loss in general or if the cause of death matters. Whether such a...
2.
Larsson H, Asherson P, Chang Z, Ljung T, Friedrichs B, Larsson J, et al.
Psychol Med
. 2012 Aug;
43(1):197-207.
PMID: 22894944
Background: Attention deficit hyperactivity disorder (ADHD) frequently persists into adulthood. Family and twin studies delineate a disorder with strong genetic influences among children and adolescents based on parent- and teacher-reported...
3.
Jonsdottir I, Nordlund A, Ellbin S, Ljung T, Glise K, Wahrborg P, et al.
Stress
. 2012 Jul;
16(2):181-90.
PMID: 22746338
Patients who seek medical care for stress-related mental health problems frequently report cognitive impairments as the most pronounced symptom. The purpose of the present study was to compare cognitive function...
4.
Ljung T, Lichtenstein P, Sandin S, DOnofrio B, Runeson B, Langstrom N, et al.
Psychol Med
. 2012 Jun;
43(3):581-90.
PMID: 22703756
Background: Little is known about suicide risk among offspring of parents hospitalized for schizophrenia and the mechanisms behind this association. Method: We applied a nested case-control design based on linkage...
5.
Ljung T, Axelsson L, Herulf M, Lundberg J, Hellstrom P
Aliment Pharmacol Ther
. 2007 Apr;
25(8):925-32.
PMID: 17402996
Background: Treatment with tumor necrosis factor-alpha monoclonal antibody (infliximab) reduces clinical activity and intestinal inflammation in Crohn's disease. Aim: To study the time-course of the effects of infliximab with reference...
6.
Ljung T, Karlen P, Schmidt D, Hellstrom P, Lapidus A, Janczewska I, et al.
Gut
. 2004 May;
53(6):849-53.
PMID: 15138212
Background: Several placebo controlled studies have demonstrated the efficacy of infliximab in inflammatory bowel disease (IBD) but the potential toxicity of this new biological compound has been less studied. Aim:...
7.
Wallerius S, Rosmond R, Ljung T, Holm G, Bjorntorp P
J Endocrinol Invest
. 2003 Nov;
26(7):616-9.
PMID: 14594110
An abnormal regulation of the hypothalamic-pituitary-adrenal (HPA) axis is associated with risk factors for cardiovascular disease and Type 2 diabetes mellitus. The objective of this study was to examine if...
8.
Ljung T, Staun M, Grove O, Fausa O, Vatn M, Hellstrom P
Scand J Gastroenterol
. 2002 Oct;
37(9):1108-10.
PMID: 12374238
Eight patients with pyoderma gangrenosum associated with Crohn disease were treated with infliximab. All had active mucosal inflammation indicated by endoscopic examination. Within 1-4 months, infliximab treatment resulted in complete...
9.
Befrits R, Ljung T, Jaramillo E, Rubio C
Dis Colon Rectum
. 2002 May;
45(5):615-20.
PMID: 12004210
Purpose: Extensive, long-standing inflammatory bowel disease is associated with an increased risk of developing colorectal carcinoma. Low-grade dysplasia has been used as a marker for malignant transformation and by some...
10.
Ljung T, Ottosson M, Ahlberg A, Eden S, Oden B, Okret S, et al.
J Endocrinol Invest
. 2002 Apr;
25(3):229-35.
PMID: 11936464
Abdominal obesity seems to be associated with a moderately deranged feedback regulation of the hypothalamic-pituitary-adrenal (HPA) axis where central glucocorticoid receptors (GR) are involved. Therefore, functions of central and peripheral...